Currently, Søren Tulstrup occupies the position of President & Chief Executive Officer for Hansa Biopharma AB. Mr. Tulstrup is also Senior Vice President for Shire Human Genetic Therapies, Inc.

Mr. Tulstrup previously was Chief Executive Officer for Vifor Pharma AG and Chief Executive Officer of Vifor Pharma Management AG (a subsidiary of Vifor Pharma AG), Vice President-Global Human Health at Merck & Co., Inc. and Managing Director-Denmark at Merck Sharp & Dohme Ltd. (a subsidiary of Merck & Co., Inc.), Deputy Regional Manager at Novartis AG and Principal at Sandoz, Inc. (a subsidiary of Novartis AG), Principal at Abbott Laboratories, President & Chief Executive Officer for Roche Innovation Center Copenhagen An and Senior Vice President for Shire Pharmaceuticals, Inc.

He received a graduate degree from Copenhagen Business School and a graduate degree from Northwestern University.